Back
argenx SE 10K Form
Sell
46
ARGX
argenx SE
Last Price:
$608.34
Seasonality Move:
21.14%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ARGX News And Ratings
See the #1 stock for the next 7 days that we like better than ARGX
ARGX Financial Statistics
Sales & Book Value
| Annual Sales: | $2.2B |
|---|---|
| Cash Flow: | $-147M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $90.49 |
| Price / Book: | 6.82 |
Profitability
| EPS (TTM): | 12.71000 |
|---|---|
| Net Income (TTM): | $833M |
| Gross Margin: | $2B |
| Return on Equity: | 21.33% |
| Return on Assets: | 16.08% |
argenx SE Earnings Forecast
Key argenx SE Financial Ratios
-
The Gross Profit Margin over the past 5 years for ARGX is 89.62%.
-
The Selling, General & Administrative Expenses for ARGX have been equal to 48.04% of Gross Profit Margin.
-
The Research & Development expenses have been 44.90% of Revenue.
-
The Interest Expense is 0.30% of Operating Income.
-
The Net Earning history of ARGX is 38.03% of Total Revenues.
-
Per Share Earnings over the last 14 years have been positive in 5 years.
argenx SE Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ARGX |
| CUSIP: | 04016X |
| Website: | argenx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 7.29 |
| Quick Ratio: | 6.4 |
Price-to-Earnings
| Trailing P/E Ratio: | 48.12 |
|---|---|
| Forward P/E Ratio: | 27.72 |